*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Cystatin C Assessment In Pediatric ?-Thalassemia Major And Intermedia: A Marker Of Subclinical Cardiovascular Dysfunction

Author: MOHAMED BESHIR, DIANA HANNA, NAGLAA KHALIFA, AHMED ELHEWALA
Abstract: Background: Cardiovascular complications represent the main determinant of survival in ß-thalassemia patients, with particular pattern of cardiovascular affection inß-thalassemia major (ß-TM) and ß-thalassemia intermedia (ß-TI). Serum cystatin C is a well-known predictor of nephropathy but it has emerged as a strong predictor to cardiovascular dysfunction. Objective: We assessedcystatin C levels in children and adolescents with ß-TM and ß-TI and its relation to echocardiography parameters and carotid intima media thickness (CIMT) as a marker of subclinical cardiovascular dysfunction. Methods: Case control study on 60 patients with ß-TM, 30 patients with ß-TI and 60 age- and sex- matched controls focusing on hematological profile, serum ferritin, urinary albumin–creatinine ratio (UACR),serum cystatin C, echocardiography and CIMT. Results: UACR, serum cystatin C and CIMT were significantly higher in ß-TM and ß-TIgroups compared to control (P < 0.001). Cardiac left ventricle (LV) systolic dysfunction was more prominent in patients with ß-TM (30%) versus (13.33%) in ß-TI, while significantly higher pulmonary pressure in those with ß-TI(73.3%) compared to (43.3%) of ß-TM. Significantly higher cystatin C levels were observed in ß-TM and ß-TI patients with nephropathy, LV systolic dysfunction or pulmonary hypertension than those without. Cystatin C levels were positively correlated with CIMT in both ß-TM and ß-TI groups. Thecystatin C cutoff valuesfor detection of the risk of cardiovascular complications were assessed. Conclusions: Cystatin C appears to be a promising a marker for subclinical cardiovascular dysfunction in ß-TM and ß-TI patients.
Keyword: Cystatin C, ß-thalassemia, Cardiovascular, Nephropathy, Carotid intima media thickness.
DOI: https://doi.org/10.31838/ijpr/2020.12.04.652
Download: Request For Article
 
Clients

Clients

Clients

Clients

Clients
ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free